Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 1.4T | 3.9T | 2.3T | 2.3T |
Cost of revenue | 1.1T | 3.5T | 1.9T | 2.0T |
Gross profit | 255.3B | 384.8B | 435.2B | 278.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 116.6B | 280.9B | 205.6B | 151.8B |
Other operating expenses | 34.8B | 1.5T | -34.7B | -27.5B |
Operating income | -141.6B | -1.6T | 112.7B | -81.5B |
Non operating interest income | ||||
Income | 142.4B | 183.2B | 262.2B | 296.2B |
Expense | 901.7B | 880.1B | 1.2T | 1.2T |
Other income expense | — | — | — | — |
Pretax income | -1.4T | -293.1B | -1.0T | -1.5T |
Tax provision | 4.4B | 6.0B | 8.3B | 13.5B |
Net income | -1.4T | -299.1B | -1.0T | -1.5T |
Basic EPS | -43.3 | — | — | — |
Diluted EPS | -43.3 | — | — | — |
Basic average shares | 28.8B | — | — | — |
Diluted average shares | 28.8B | — | — | — |
EBITDA | -80.6B | -2.0T | 496.5B | 127.7B |
Net income from continuing op. | — | — | — | — |
Minority interests | 118.0B | 712.0B | 168.1B | 326.2B |
Preferred stock dividends | 0 | 0 | 0 | 0 |